Airsculpt Technologies is trading 6% down in pre-market at $2.90 as investors continue digesting the second-quarter earnings miss and reduced full-year adjusted EBITDA outlook.
- Q2 revenue was $42.9 million versus a $44.2 million consensus estimate.
- Management lowered adjusted EBITDA guidance to $12–$14 million and reaffirmed revenue at the lower end of $151–$157 million.
- The stock closed August 17 at $3.08, down 10.06%.